In summary, this study implies that FAM13A mediates TGF-β1-induced EMT in small airways in COPD, providing FAM13A as a potential therapeutic target for anti-EMT treatment of COPD. The gene discussed is TGFB1; the disease is chronic obstructive pulmonary disease.